DGAT2 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DGAT2 inhibitor, covering 2023-04-13 to 2023-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis [Phase 2]